Related Experiment Video
Updated: Aug 6, 2025
A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Suprathel® or Mepilex® Ag for treatment of partial thickness burns in children: A case control study
Matilda Karlsson1, Ingrid Steinvall1, Moustafa Elmasry1
1Department of Hand Surgery, Plastic Surgery and Burns, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Insights
Suprathel® and Mepilex® Ag dressings show similar effectiveness for treating pediatric partial-thickness scalds. Both treatments resulted in comparable healing times, infection rates, and surgical interventions, indicating Suprathel® as a viable alternative.
Area of Science:
- Pediatric Burn Care
- Wound Management
- Dermatology
Background:
- Partial-thickness scalds are common pediatric injuries requiring effective wound management.
- Current treatments include silver-impregnated dressings like Mepilex® Ag.
- Novel dressings such as Suprathel® are being explored as alternatives.
Purpose of the Study:
- To evaluate Suprathel® as a potential alternative to Mepilex® Ag for treating partial-thickness scalds in children.
- To compare the clinical outcomes of Suprathel® versus Mepilex® Ag in pediatric burn patients.
Main Methods:
- Retrospective study of 58 children with partial-thickness scalds treated between 2015-2022.
- Comparison of outcomes between 30 children treated with Suprathel® and 28 treated with Mepilex® Ag.
- Investigated outcomes included healing time, burn wound infection (BWI), need for operations, and dressing changes.
Main Results:
- No significant differences were observed between Suprathel® and Mepilex® Ag groups for any outcome.
- Similar healing within 14 days (17/30 Suprathel® vs. 15/28 Mepilex® Ag).
- Identical rates of antibiotic use for suspected BWI (10/group) and skin grafting operations (2/group); median of four dressing changes per group.
Conclusions:
- Suprathel® demonstrates comparable efficacy to Mepilex® Ag in managing pediatric partial-thickness scalds.
- Both dressings yield similar healing times, infection rates, and surgical intervention needs.
- Suprathel® presents a viable alternative treatment option for this patient population.
Aim:
The study aim was to investigate if Suprathel® can be an adequate alternative to Mepilex® Ag for the treatment of partial-thickness scalds in children.
Methods:
A retrospective study including 58 children admitted to The Burn Centre in Linköping, Sweden between year 2015 and 2022. Of the 58 children, 30 were dressed with Suprathel ® and 28 with Mepilex ® Ag. Outcomes investigated were healing time, burn wound infection (BWI), need for operations and number of dressing changes.
Results:
We found no significant differences in any of the outcomes. In the Suprathel ® group 17 children and in the Mepilex ® Ag group 15 children were healed within 14 days. Ten children from each group received antibiotics for suspected BWI and two from each group underwent an operation with skin grafting. Each group had on median four dressing changes.
Conclusions:
Two different treatments were compared for children with partial-thickness scalds, and the data indicates that similar results are received with both dressings.
More Related Videos
Related Concept Videos
01:19Clinical Applications of Epidermal Stem Cells
01:22Burn Injuries
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...